Vivici, a Dutch startup backed by multinational dsm-firmenich and dairy multinational Fonterra, has raised €32.5 million in a Series A funding round. The financing round was led by APG – on behalf of pension fund ABP – and Invest-NL. InnovationQuarter also participated in the investment round, in addition to existing shareholders dsm-firmenich and Fonterra. With this investment, Vivici can take the next step towards further scaling up and commercialization. Vivici was founded in 2023 with the mission to realize the commercial potential of precision fermentation. Precision fermentation – the method Vivici uses to make dairy protein – combines the process of traditional fermentation with modern biotechnology. This technology makes it possible to produce high-quality proteins without the use of animals. In this way, the company meets the protein needs of a growing world population in a sustainable way, without compromising on price, taste or nutritional value. Olym advised APG, Invest-NL and InnovationQuarter in this transaction.